Media Summary: FOCUS: Fixed-dose combination drug for secondary cardiovascular Ezetimibe/Simvastatin vs Simvastatin monotherapy on cardiovascular outcomes after ACS. For more resources from the Rosk/Benefit of prolonged DAPT after DES. For more resources from the
Ehj Today Guidelines On Cvd Prevention - Detailed Analysis & Overview
FOCUS: Fixed-dose combination drug for secondary cardiovascular Ezetimibe/Simvastatin vs Simvastatin monotherapy on cardiovascular outcomes after ACS. For more resources from the Rosk/Benefit of prolonged DAPT after DES. For more resources from the
